10:30 – 11:15 AM
Breast Imaging Today: New Technologies, Clinical Challenges, and Practical Pearls
Moderators: Saly Zahra & Ameya Kulkarni

  • Dr. Kulkarni has disclosed involvement in funded research supported by the Hamilton Health Sciences Foundation and the New Frontiers in Research Fund (NFRF). He serves as a Co-Principal Investigator and Co-Investigator on these funded research initiatives.

Navigating Breast Density: From Risk Assessment to Supplemental Screening
Isabelle Zheng

Post-Surgical Breast Imaging: Pearls and Pitfalls
Zina Kellow

  • Dr. Zellow has disclosed receiving honoraria from the Canadian Society of Breast Imaging for presentations and educational speaking activities.

= = = 

11:20 – 12:05 PM
Critical Decisions in Neuroimaging: Guidelines, Mimics, and Emerging Practice
Moderators: Laurent Létourneau-Guillon & Eduardo Portela De Oliveira

Spinal Cord Imaging for Clinical Practice in Multiple Sclerosis: How and When? Update on the New MAGNIMS Criteria and Advanced Sequences
Blanche Bapst

  • This presentation will outline the critical role of spinal cord MRI in diagnosing and monitoring Multiple Sclerosis, highlighting the latest MAGNIMS consensus guidelines. It will provide practical guidance on optimal imaging protocols, with a special emphasis on the emerging clinical utility of non-enhanced heavily T1-weighted imaging for spinal cord imaging (MP2RAGE, FLAWS, WM-nulled imaging).
  • Target Audience: Radiologist, Resident
  • At the end of this presentation, delegates will be able to:
    • Apply the 2024 McDonald and MAGNIMS recommendations to optimize MRI protocol selection for comprehensive spinal cord evaluation in clinical practice.
    • Assess the clinical rationale and diagnostic value of novel heavily T1-weighted sequences for the diagnosis and longitudinal follow-up of Multiple Sclerosis.
  • CanMEDS Roles: Medical Expert, Scholar

Clinical Perspective: Stroke Guidelines & Imaging's Impact on Workflow
Laura Gioia

  • This presentation will review current Canadian (and international) acute stroke guidelines from a clinician’s perspective and examines the role of imaging in expanding treatment eligibility, as well as new frontiers (prehospital setting).
  • Target Audience: Radiologist, Resident, Medical Student
  • At the end of this presentation, delegates will be able to:
    • Describe current Canadian and international acute stroke guideline recommendations for imaging selection, including the role of CTA and CT perfusion in extended-window and large-core thrombectomy.
    • Identify practical workflow strategies, such as streamlined imaging protocols and AI-assisted triage, to expedite guideline-driven treatment timelines.
  • CanMEDS Roles: Medical Expert, Communicator, Leader, Health Advocate
  • Dr. Gioia has received speaker honoraria from Bayer and AstraZeneca Canada; is an advisory board member for Bayer and AstraZeneca Canada; and received funded research studies and/or salary support from the Heart and Stroke Foundation, CIHR, Brain Canada, FRQS, and AstraZeneca Canada.